Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Basal Cell Cancer
Research on basal cell cancer discussed by C. Lawrence and co-researchers
March 31st, 2009
According to recent research from the United Kingdom, "Mohs surgery using a formalin-fixed tissue technique (slow Mohs) was used to treat 1090 basal cell carcinomas (BCCs) occurring in 1000 patients without Gorlin syndrome in a prospective, open nonrandomized trial of therapy carried out in a university dermatology department. To record outcomes and 5-year cure rates in these patients." "Five multirecurrent BCCs could not be cleared and Mohs surgery was abandoned. In the remaining 1085 BCCs, after debulking, clearance was achieved with a mean of 1.7 stages and 7.7 blocks. Logistic regression analysis showed that large tumour size and position on the nose were the only...
Source: Cancer Weekly (2009-03-31)
|
